nach oben

Erschienen in:

2020 | OriginalPaper | Buchkapitel

72. Genetische Defekte der Fettsäurenoxidation und des Ketonstoffwechsels

verfasst von : Ute Spiekerkötter

Erschienen in: Pädiatrie

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Den Störungen der mitochondrialen Fettsäurenoxidation und des Ketonstoffwechsels liegen autosomal-rezessiv vererbte Enzym- oder Transporterdefekte zugrunde. Erst in den letzten 25 Jahren wurden viele dieser inzwischen mehr als 20 Defekte erstmals identifiziert. Angeborene Störungen des Riboflavin-Metabolismus gehören mittlerweile auch zu den Störungen der Fettsäurenoxidation.

Andresen BS, Dobrowolski SF, O’Reilly L et al (2001) Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet 68:1408–1418PubMedPubMedCentralCrossRef

Arbeitsgemeinschaft der wissenschaftlichen medizinischen Fachgesellschaften e.V. (AWMF). http://www.awmf.org/leitlinien

Boer ME den, Wanders RJ, Morris AA et al (2002) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Clinical presentation and follow-up of 50 patients. Pediatrics 109:99–104

Clayton PT, Eaton S, Aynsley-Green A et al (2001) Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest 108:457–465PubMedPubMedCentralCrossRef

Copeland WC (2012) Defects in mitochondrial DNA replication and human disease. Crit Rev Biochem Mol Biol 47:64–74PubMedPubMedCentralCrossRef

Corr PB, Creer MH, Yamada KA et al (1989) Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 83:927–936PubMedPubMedCentralCrossRef

Dang CV (2012) Links between metabolism and cancer. Genes Dev 26:877–890PubMedPubMedCentralCrossRef

DiMauro S (2011) A history of mitochondrial diseases. J Inherit Metab Dis 34:261–276PubMedCrossRef

DiMauro S, Rustin P (2009) A critical approach to the therapy of mitochondrial respiratory chain and oxidative phosphorylation diseases. Biochim Biophys Acta 1792:1159–1167PubMedCrossRef

Frederiksen AL et al (2006) Tissue specific distribution of the 3243A→G mtDNA mutation. J Med Genet 43:671–677PubMedPubMedCentralCrossRef

Gillingham MB, Weleber RG, Neuringer M et al (2005) Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency. Mol Genet Metab 86:124–133PubMedPubMedCentralCrossRef

Gillingham MB, Harding CO, Goldstein A et al (2015) Triheptanoin lowers cardiac workload compared to medium-chain triglyceride in patients with long-chain fatty acid oxidation disorders. J Inherit Metab Dis 38:S195

Graff C, Clayton DA, Larsson NG (1999) Mitochondrial medicine-recent advances. J Intern Med 246:11–23PubMedCrossRef

Grunert SC (2014) Clinical and genetic heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency. Orphanet J Rare Dis 9:117PubMedPubMedCentralCrossRef

Haack TB, Haberberger B, Frisch EM et al (2012) Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing. J Med Genet 49:277–283PubMedCrossRef

Hempel M, Haack TB, Prokisch H (2011) Next generation sequencing. Monatsschr Kinderheilk 159:827–833CrossRef

Hoffmann L, Haussmann U, Mueller M et al (2011) VLCAD enzyme activity determinations in newborns identified by screening: a valuable tool for risk assessment. J Inherit Metab Dis 35(2):269–277PubMedCrossRef

Kamp JM van de, Mancini GMS, Pouwels PJW et al (2011) Clinical features and X-inactivation in females heterozygous for creatine transporter defect. Clin Genet 79:264–272

Klepper J, Leiendecker B, Bredahl R et al (2002) Introduction of a ketogenic diet in young infants. J Inherit Metab Dis 25:449–460CrossRefPubMed

Koga Y, Akita Y, Nishioka J et al (2005) L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 64:710–712PubMedCrossRef

Koopman WJH, Willems PHGM, Smeitink JAM (2012) Monogenic mitochondrial disorders. N Engl J Med 366:1132–1141PubMedCrossRef

Luft R (1995) The development of mitochondrial medicine. Biochim Biophys Acta 1271:1–6PubMedCrossRef

Maldegem BT van, Duran M, Wanders RJ et al (2006) Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency. JAMA 296:943–952

Mayr JA, Freisinger P, Schlachter K et al (2011) Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway. Am J Hum Genet 89:806–812PubMedPubMedCentralCrossRef

Olsen RK, Olpin SE, Andresen BS et al (2007) ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain 130:2045–2054PubMedCrossRef

Olsen RKJ, Holzerova E, Giancaspero TA et al (2016) Riboflavin-responsive and non-responsive mutations in the FAD synthase gene cause multiple acyl-CoA dehydrogenase and combined respiratory chain deficiency. Am J Hum Genet 98:1130–1145PubMedPubMedCentralCrossRef

Orngreen MC, Madsen KL, Preisler N et al (2014) Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial. Neurology 82:607–613PubMedPubMedCentralCrossRef

Primassin S, Ter Veld F, Mayatepek E et al (2008) Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine. Pediatr Res 63:632–637PubMedCrossRef

Rhead W (2015) Short-chain acyl-CoA dehydrogenase deficiency is not a disease: common ACADS variants and mutations have no clinical significance. J Inherit Metab Dis 38:S186

Rosenberg EH, Almeida LS, Kleefstra T et al (2004) High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am J Hum Genet 75:97–105PubMedPubMedCentralCrossRef

Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF (2004) The epidemiology of mitochondrial disorders – past, present and future. Biochim Biophys Acta 1659:115–120PubMedCrossRef

Schiff M, Veauville-Merllie A, Su CH et al (2016) SLC25A32 mutations and riboflavin-responsive exercise intolerance. N Engl J Med 374:795–797PubMedPubMedCentralCrossRef

Schulze A (2004) Angeborene Störungen des Kreatinstoffwechsels (Kreatinmangelsyndrome). In: Hoffmann G, Grau AJ (Hrsg) Stoffwechselerkrankungen in der Neurologie. Thieme, Stuttgart, S 102–128

Schulze A, Hoffmann GF, Bachert P et al (2006) Successful pre-symptomatic diagnosis and treatment from birth in GAMT deficiency. Neurology 67:719–721PubMedCrossRef

Skladal D, Halliday J, Thorburn DR (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126:1905–1912PubMedCrossRef

Sperl W, Prokisch H, Karall D, Mayr JA, Freisinger P (2011) Mitochondriopathien, ein Update. Monatsschr Kinderheilk 9:848–854CrossRef

Spiekerkoetter U, Tenenbaum T, Hensch A, Wendel U (2003) Cardiomyopathy and pericardial effusion in infancy point to a fatty acid β-Oxidation defect after exclusion of an underlying infection. Pediat Cardiol 24:295–297

Spiekerkoetter U, Khuchua Z, Yue Z et al (2004) General mitochondrial trifunctional protein (TFP) deficiency as a result of either alpha- or beta-subunit mutations exhibits similar phenotypes because mutations in either subunit alter TFP complex expression and subunit turnover. Pediatr Res 55:190–196PubMedCrossRef

Spiekerkoetter U, Lindner M, Santer R et al (2009) Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis 32:498–505PubMedCrossRef

Spiekerkoetter U, Haussmann U, Mueller M et al (2010) Tandem mass spectrometry screening for very long-chain acyl-CoA dehydrogenase deficiency: the value of second-tier enzyme testing. J Pediatr 157:668–673PubMedCrossRef

Stickler DE, Valenstein E, Neiberger RE et al (2006) Peripheral neuropathy in genetic mitochondrial diseases. Pediatr Neurol 34:127–131PubMedCrossRef

Taroni F, Verderio E, Dworzak F et al (1993) Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients. Nat Genet 4:314–320PubMedCrossRef

Tyni T, Kivela T, Lappi M et al (1998) Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy. Ophthalmology 105:810–824PubMedCrossRef

Van Hove JL, Grunewald S, Jaeken J et al (2003) D, L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD). Lancet 361:1433–1435PubMedCrossRef

Wallace DC, Fan W, Procaccio V (2010) Mitochondrial energetics and therapeutics. Annu Rev Pathol Mech Dis 5:297–348CrossRef

Wanders RJ, Ruiter JP, Ijlst L et al (2010) The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results. J Inherit Metab Dis 33(5):479–494PubMedPubMedCentralCrossRef

Wenz T, Williams SL, Bacman SR et al (2010) Emerging therapeutic approaches to mitochondrial diseases. Dev Disabil Res Rev 16:219–229PubMedCrossRef

Wilcken B (2010) Fatty acid oxidation disorders: outcome and long-term prognosis. J Inherit Metab Dis 33:501–506PubMedCrossRef

Wilcken B, Leung KC, Hammond J et al (1993) Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet 341:407–408PubMedCrossRef

Wilcken B, Haas M, Joy P et al (2007) Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet 369:37–42PubMedCrossRef

Wortmann SB, Rodenburg RJ, Jonckheere A et al (2009) Biochemical and genetic analysis of 3-methylglutaconic aciduria type IV: a diagnostic strategy. Brain 132:136–146PubMedCrossRef

Titel: Genetische Defekte der Fettsäurenoxidation und des Ketonstoffwechsels
verfasst von: Ute Spiekerkötter
Verlag: Springer Berlin Heidelberg
Buch: Pädiatrie
Print ISBN: 978-3-662-60299-7

Electronic ISBN: 978-3-662-60300-0

Copyright-Jahr: 2020
DOI: https://doi.org/10.1007/978-3-662-60300-0_75

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

72. Genetische Defekte der Fettsäurenoxidation und des Ketonstoffwechsels

Zusammenfassung

Neu im Fachgebiet Pädiatrie

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Bei Amblyopie früher abkleben als bisher empfohlen?

Update Pädiatrie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Pädiatrie

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Bei Amblyopie früher abkleben als bisher empfohlen?

Update Pädiatrie